MSF frequently publishes updates, press releases, and other forms of communication about its work in roughly 70 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Filter by vocabulary: issues (multisite):

Since the start of 2008, 767 people suffering from cholera have required treatment in a cholera treatment center (CTC) supported by Doctors Without Borders/Médecins Sans Frontières (MSF) the city of Lubumbashi, the capital of Katanga province and the economic center of the Democratic Republic of the Congo.

More >

New York, 11 April 2007 – Since cholera was confirmed in Mogadishu on March19, 2007, the international humanitarian medical aid organization Doctors Without Borders/Médecins Sans Frontières (MSF) has treated more than 800 patients. However the recent worsening violence is making it increasingly difficult for patients to access MSF's cholera treatment center (CTC), which opened two weeks ago. The fighting is also preventing MSF national staff from reaching other areas of the city.

More >

Southern Sudan has paid one of the highest prices among countries affected by meningitis this year. Several teams from Doctors Without Borders/Médecins sans Frontières (MSF) are caring for those affected by the deadly epidemic and vaccinating the population at risk throughout a number of states in the region. To make matters worse, cholera is quickly progressing in a number of areas.

More >

Atlanta, November 15, 2006 — In research presented at the 55th Annual Meeting of the American Society of Tropical Medicine and Hygiene (ASTMH), the international emergency medical aid organization Doctors Without Borders/Médecins Sans Frontières (MSF) and its research affiliate, Epicentre, showed how rapid, mass vaccinations can reduce the toll inflicted by measles epidemics in Africa. In light of these and other findings, MSF feels there is enough evidence for the WHO to revise its current policy recommendations, which doubts the effectiveness of mass immunization once an epidemic has started, stating that such campaigns would be undertaken too late to have any meaningful impact.

More >

Kinshasa/Brussels, March 13, 2006 - The international humanitarian aid organization Doctors Without Borders/Médecins Sans Frontières (MSF) is launching a massive measles vaccination campaign in Mbuji Mayi (Kasai Oriental province), the second largest city in the Democratic Republic of Congo (DRC). In only a few weeks, MSF teams will vaccinate an estimated 550,000 children under the age of 5.

More >

April 28, 2005, N’Djamena/New York - A measles epidemic has hit at least three provinces in Southern and Eastern Chad, as well as the capital, N’Djamena. Doctors Without Borders/Médecins Sans Frontières (MSF) has started to provide emergency assistance by treating patients with measles, continuing assessments, and carrying out vaccination campaigns.

More >

MSF is launching a meningitis vaccination campaign in eastern Chad, following a recent outbreak among refugees from Sudan's Darfur region.

More >

New York, April 28, 2004 - Because of the lack of appropriate, urgently needed aid, the health of displaced people in Sudan's Darfur region - particularly children - is radically worsening, according to the international medical aid organization Doctors Without Borders/Médecins Sans Frontières (MSF).

More >

Geneva, September 25th 2003 - The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) warns that thousands of lives could be lost in Africa if donors fail to fund the production of a new meningitis vaccine in the next two weeks. Prompt action is needed to ensure supplies will be available when the next meningitis epidemic season begins in Africa in late 2003 or early 2004. So far, MSF is the only organization to allocate funds (€ 1 million) to purchase the vaccine.

More >

Geneva, February 6, 2003 - Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the new trivalent (ACW135) meningitis vaccine developed by GlaxoSmithKline. MSF is particularly encouraged to see that the new product was registered so quickly, in only a few months, while last August, companies and regulatory authorities still argued such a quick maneuver wouldn't be feasible.

More >

Pages